Live Breaking News & Updates on Hemolysis

Stay informed with the latest breaking news from Hemolysis on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Hemolysis and stay connected to the pulse of your community

Europe Approves Paroxysmal Nocturnal Hemoglobinuria Drug

The factor D inhibitor danicopan has been approved for use in Europe for patients with paroxysmal nocturnal hemoglobinuria with residual hemolytic anemia on standard therapy.

Japan , European-union , European-medicines-agency , European-commission , Drug-administration , Priority-medicines , Medicinal-products , Human-use , Paroxysmal-nocturnal-hemoglobinuria , Nh-paroxysmal-nocturnal-hemoglobinuria , Aroxysmal-nocturnal-haemoglobinuria

FDA OKs Danicopan for Extravascular Hemolysis in PNH

A tablet has been approved for a common complication during treatment for a rare blood disorder.

Astrazeneca , Drug-administration , Risk-evaluation , Mitigation-strategy , Patient-safety , Hemolysis , Blood , Blood-transfusion , Thromboembolism , Thrombus , Lood-clot

Complement Inhibitors may be Ineffective for Reducing Omicron Infection Severity

A single-center study suggests complement inhibitors do not reduce the severity of a COVID-19 Omicron infection in patients with paroxysmal nocturnal hemoglobinuria (PNH).

China , Union-medical-college-hospital , Red-blood-cells , Peking-union-medical-college-hospital , Rare-blood-disorders , Paroxysmal-nocturnal-hemoglobinuria , Pnh , Covid-19 , Omicron , Covid-19-vaccine , Hemolysis

Can Higher Dose Primaquine Shorten Malaria Treatment?

A short course of higher-dose primaquine was effective in preventing relapse of P vivax malaria.

Afghanistan , United-states , Brazil , Vietnam , Republic-of , Cruzeiro-do-sul , Santa-catarina , Indonesia , Venezuela , Ethiopia , America , Brazilian

FDA Approves First Drug for Rare Inherited Anemia

Mitapivat (Pyrukynd) is the first disease-modifying agent for hemolytic anemia in adults with pyruvate kinase (PK) deficiency.

Boston , Massachusetts , United-states , Agios-inc , European-union , Drug-administration , Rachael-grace , Boston-children , Anemia , Hematology , Hemolytic-anemia

FDA Approves First Drug for Cold Agglutinin Disease

Sutimlimab-jome is the first drug to have FDA approval for the treatment cold agglutinin disease, a rare autoimmune hemolytic anemia in which antibodies destroy red blood cells.

United-states , Japan , Catherine-broome , Georgetown-university-lombardi-comprehensive-cancer-center , Drug-administration , Anemia , Blood-transfusion , Cold-agglutinin-disease , Hematology , Rare-diseases , Us-food-and-drug-administration , Nited-states-food-and-drug-administration

Woman who survived health scare said blood donation saved her and her baby

Woman who survived health scare said blood donation saved her and her baby
Katherine Bredemeier said she had unusual pain 38 weeks into her pregnancy
Share
Updated: 5:27 PM CST Jan 25, 2021
Katherine Bredemeier said she had unusual pain 38 weeks into her pregnancy
Share
Updated: 5:27 PM CST Jan 25, 2021
Hide Transcript
Show Transcript
THIS IS A MOMENT THAT ALMOST DIDN’T HAPPEN CATHERINE BERETTA MEYER AT NORTH KANSAS CITY HOSPITAL HOLDING HER FIRSTBORN CHILD WILLIAM FOR THE FIRST TIME 38 WEEKS INTO HER PREGNANCY. SHE HAD AN UNUSUAL PAIN HER LIVER HAD ERUPTED AND SHE WOULD NEED A MASSIVE BLO TRANSFUSION. WHAT SOLIDIFIED HOW BAD IT REALLY

Kansas , United-states , Katherine-bredemeier , Kelly-eckerman , Patrick-mahomes , William-patrick , Shoal-creek-elementary-school-in-liberty , North-kansas-city-hospital , Shoal-creek-elementary-school , Kansas-city , Missouri , Liberty